CALAN Side Effects

6803435-2 | Asthenia, Dizziness, Extrasystoles, Hip Fracture, Hypertension, Infection, Malaise, Nausea, Osteoarthritis
on Jun 18, 2010 Female patient from UNITED STATES , weighting 119.0 lb, was diagnosed with cardiac disorder, blood cholesterol increased and was treated with Calan (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, dizziness (What is dizziness?), extrasystoles, hip fracture, hypertension, infection (What is infection?), malaise, nausea (What is nausea?), osteoarthritis (What is osteoarthritis?). Calan dosage: Unk. During the same period patient was treated with VERAPAMIL (Unk) (View Verapamil Review and Verapamil Label ), HYDROCHLOROTHIAZIDE (25 Mg, 2x/day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), IPRATROPIUM (Unk) (View Ipratropium Review and Ipratropium Label ), KLOR CON (20 Mg, Alternate Day) (View Klor-con Review and Klor-con Label ), CRESTOR (10 Mg, 1x/day) (View Crestor Review and Crestor Label ), VALSARTAN (320 Mg, 1x/day) (View Valsartan Review and Valsartan Label ), LACTULOSE (Unk) (View Lactulose Review and Lactulose Label ), VITAMIN E (Unk) (View Vitamin E Review and Vitamin E Label ). Patient was hospitalized.

6793956-3 | Presyncope, Visual Impairment
Patient was taking Calan (View Usage). Patient had the following side effects: presyncope, visual impairment on May 29, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 170.0 lb, was diagnosed with hypertension and. Calan dosage: 240 Mg, 1x/day. During the same period patient was treated with SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ), MEVACOR (Unk) (View Mevacor Review and Mevacor Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

6788860-0 | Blood Pressure Inadequately Controlled, Depressed Level Of Consciousness, Insomnia
Adverse event was reported on Jul 02, 2008 by a Female patient taking Calan (View Usage) (Dosage: ) . Location: UNITED STATES , 74 years of age, After Calan was administered, patient had the following side effects: blood pressure inadequately controlled, depressed level of consciousness, insomnia.

6558695-2 | Ovarian Cancer
on Jan 18, 2010 Female patient from UNITED STATES , weighting 132.3 lb, was diagnosed with hypertension and was treated with Calan (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian cancer. Calan dosage: 240mg In Morning, 120mg At Night. During the same period patient was treated with COENZYME Q10 (Unk) (View Coenzyme Q10 Review and Coenzyme Q10 Label ).


6183575-4 | Abdominal Discomfort, Diarrhoea, Hernia, Sleep Disorder, Weight Increased
on Apr 27, 2009 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with hypertension, diabetes mellitus and was treated with Calan (View Usage). Patient had the following side effects: abdominal discomfort, diarrhoea, hernia (What is hernia?), sleep disorder (What is sleep disorder?), weight increased. Calan dosage: . During the same period patient was treated with CATAPRES (View Catapres Review and Catapres Label ), AMARYL (View Amaryl Review and Amaryl Label ), BENICAR (View Benicar Review and Benicar Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), NEXIUM (View Nexium Review and Nexium Label ), IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5943767-3 | Dysarthria, Fatigue
Patient was taking Calan (View Usage). After Calan was administered, patient had the following side effects: dysarthria, fatigue on Oct 27, 2008 from UNITED STATES Additional patient health information: Female patient , 83 years of age, was diagnosed with hypertension and. Calan dosage: .

5819728-1 | No Adverse Event
Adverse event was reported on Jul 12, 2008 by a Male patient taking Calan (View Usage) (Dosage: ) was diagnosed with heart disease congenital and. Location: UNITED STATES , 31 years of age, weighting 219.0 lb, Patient experienced the following unwanted or unexpected effects: no adverse event. During the same period patient was treated with DIGOXIN (Daily Dose:.25mg-freq:daily) (View Digoxin Review and Digoxin Label ), ENALAPRIL MALEATE (Daily Dose:10mg-freq:daily) (View Enalapril Maleate Review and Enalapril Maleate Label ).

5781018-3 | Diarrhoea, Sleep Disorder, Stomach Discomfort
on Jun 10, 2008 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with blood pressure (What is blood pressure?), diabetes mellitus and was treated with Calan (View Usage). Patient had the following side effects: diarrhoea, sleep disorder (What is sleep disorder?), stomach discomfort. Calan dosage: . During the same period patient was treated with CATAPRES (View Catapres Review and Catapres Label ), AMARYL (View Amaryl Review and Amaryl Label ), BENICAR (View Benicar Review and Benicar Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

5690314-X | Cardiac Failure Congestive, Viral Infection
on Mar 31, 2008 Female patient from UNITED STATES , 46 years of age, weighting 225.0 lb, was diagnosed with hypertension and was treated with Calan (View Usage). After Calan was administered, patient had the following side effects: cardiac failure congestive, viral infection (What is viral infection?). Calan dosage: . Patient was hospitalized.

5649613-X | Arterial Occlusive Disease, Blood Pressure Inadequately Controlled, Knee Arthroplasty, Myocardial Infarction
Patient was taking Calan (View Usage). Patient experienced the following unwanted or unexpected effects: arterial occlusive disease, blood pressure inadequately controlled, knee arthroplasty, myocardial infarction on Feb 22, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 121.9 lb, was diagnosed with hypertension and. Calan dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ZOCOR (View Zocor Review and Zocor Label ).

5604893-1 | Blood Pressure Inadequately Controlled, Knee Arthroplasty, Myocardial Infarction
Adverse event was reported on Jan 16, 2008 by a Female patient taking Calan (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: UNITED STATES , weighting 121.9 lb, Patient had the following side effects: blood pressure inadequately controlled, knee arthroplasty, myocardial infarction. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ZOCOR (View Zocor Review and Zocor Label ).

5584707-9 | Anxiety, Blood Pressure Inadequately Controlled, Disability, Dizziness, Dyspnoea, Headache, Tinnitus, Weight Increased
on Dec 28, 2007 Male patient from UNITED STATES , 60 years of age, was diagnosed with hypertension and was treated with Calan (View Usage). After Calan was administered, patient had the following side effects: anxiety (What is anxiety?), blood pressure inadequately controlled, disability, dizziness (What is dizziness?), dyspnoea, headache (What is headache?), tinnitus (What is tinnitus?), weight increased. Calan dosage: Daily Dose:280mg. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5583359-1 | Blood Pressure Inadequately Controlled, Knee Arthroplasty, Myocardial Infarction
on Dec 28, 2007 Female patient from UNITED STATES , weighting 121.9 lb, was diagnosed with hypertension and was treated with Calan (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, knee arthroplasty, myocardial infarction. Calan dosage: . During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ZOCOR (View Zocor Review and Zocor Label ).

5564123-6 | Knee Arthroplasty, Myocardial Infarction
Patient was taking Calan (View Usage). Patient had the following side effects: knee arthroplasty, myocardial infarction on Dec 05, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 122.3 lb, was diagnosed with hypertension and. Calan dosage: . During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ).

4943476-3 | Intervertebral Disc Protrusion, Narcolepsy, Neck Injury, Road Traffic Accident, Rotator Cuff Syndrome, Sleep Apnoea Syndrome
Adverse event was reported on Feb 27, 2006 by a Male patient taking Calan (View Usage) (Dosage: 480 Mg (240 Mg, 2 In 1 D)) was diagnosed with hypertension and. Location: UNITED STATES , 54 years of age, weighting 280.0 lb, After Calan was administered, patient had the following side effects: intervertebral disc protrusion, narcolepsy, neck injury, road traffic accident, rotator cuff syndrome, sleep apnoea syndrome. During the same period patient was treated with CARDURA (4 Mg) (View Cardura Review and Cardura Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), ALTACE (View Altace Review and Altace Label ), PROVIGIL (View Provigil Review and Provigil Label ), RITALIN SLOW RELEASE (METHYLPHENIDATE HYDROCHLORIDE) (View Ritalin - Slow Release (methylphenidate Hydrochloride) Review and Ritalin - Slow Release (methylphenidate Hydrochloride) Label ), DRAVOCET (DEXTROPROPOXYPHENE NAPSILATE, PRACETAMOL) (View Dravocet (dextropropoxyphene Napsilate, Pracetamol) Review and Dravocet (dextropropoxyphene Napsilate, Pracetamol) Label ), ETODOLAC (View Etodolac Review and Etodolac Label ).

4941721-1 | Crohn's Disease, Depression, Nephrolithiasis
on Feb 24, 2006 Male patient from UNITED STATES , 41 years of age, weighting 215.0 lb, was diagnosed with heart rate irregular and was treated with Calan (View Usage). Patient experienced the following unwanted or unexpected effects: crohn's disease (What is crohn's disease?), depression (What is depression?), nephrolithiasis. Calan dosage: 240 Mg. During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ).

4941547-9 | Headache, Nausea, Rash
on Mar 10, 2006 Female patient from UNITED STATES , 75 years of age, weighting 207.0 lb, was diagnosed with hypertension and was treated with Calan (View Usage). Patient had the following side effects: headache (What is headache?), nausea (What is nausea?), rash (What is rash?). Calan dosage: 1 Qd. During the same period patient was treated with AVAPRO (1 Qd) (View Avapro Review and Avapro Label ).

4810560-4 | Abnormal Faeces, Activities Of Daily Living Impaired, Anhedonia, Constipation, Depressed Level Of Consciousness, Dyspepsia, Gastrointestinal Disorder, Injury, Rectal Haemorrhage
Patient was taking Calan (View Usage). After Calan was administered, patient had the following side effects: abnormal faeces, activities of daily living impaired, anhedonia, constipation (What is constipation?), depressed level of consciousness, dyspepsia, gastrointestinal disorder, injury, rectal haemorrhage on Oct 21, 2005 from UNITED STATES Additional patient health information: Male patient , 77 years of age, weighting 195.0 lb, . Calan dosage: 2 Times Daily, 250 Mgs. During the same period patient was treated with EX LAX (View Ex-lax Review and Ex-lax Label ), SENNOSIDES (View Sennosides Review and Sennosides Label ), DUCOLUX (View Ducolux Review and Ducolux Label ).

4781944-8 | Cardio-respiratory Arrest, Completed Suicide
Adverse event was reported on Sep 14, 2005 by a Female patient taking Calan (View Usage) (Dosage: Oral) was diagnosed with ill-defined disorder and. Location: UNITED STATES , 28 years of age, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, completed suicide. During the same period patient was treated with ACETAMINOPHEN (Oral) (View Acetaminophen Review and Acetaminophen Label ), CHLORPHENIRAMINE (CHLORPHENIRAMINE) (Oral) (View Chlorpheniramine (chlorpheniramine) Review and Chlorpheniramine (chlorpheniramine) Label ), BENZODIAZEPINE DERIVATIVES (BENZODIAZEPINE DERIVATIVES) (Oral) (View Benzodiazepine Derivatives (benzodiazepine Derivatives) Review and Benzodiazepine Derivatives (benzodiazepine Derivatives) Label ).

4781920-5 | Incorrect Dose Administered, Overdose
on Sep 14, 2005 Female patient from UNITED STATES , 81 years of age, was treated with Calan (View Usage). Patient had the following side effects: incorrect dose administered, overdose. Calan dosage: Oral.

4780499-1 | Completed Suicide, Intentional Misuse, Overdose
on Sep 14, 2005 Female patient from UNITED STATES , 44 years of age, was diagnosed with ill-defined disorder and was treated with Calan (View Usage). After Calan was administered, patient had the following side effects: completed suicide, intentional misuse, overdose. Calan dosage: Oral.

4780483-8 | Completed Suicide, Intentional Misuse, Overdose
Patient was taking Calan (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, intentional misuse, overdose on Sep 14, 2005 from UNITED STATES Additional patient health information: Female patient , 42 years of age, was diagnosed with ill-defined disorder and. Calan dosage: Oral.

4780458-9 | Completed Suicide, Intentional Misuse
Adverse event was reported on Sep 14, 2005 by a Female patient taking Calan (View Usage) (Dosage: Oral) was diagnosed with ill-defined disorder and. Location: UNITED STATES , 60 years of age, Patient had the following side effects: completed suicide, intentional misuse. During the same period patient was treated with MIRTAZAPINE (Oral) (View Mirtazapine Review and Mirtazapine Label ), PRAVASTATIN (Oral) (View Pravastatin Review and Pravastatin Label ).

4780442-5 | Completed Suicide, Intentional Misuse
on Sep 14, 2005 Female patient from UNITED STATES , 64 years of age, was diagnosed with ill-defined disorder and was treated with Calan (View Usage). After Calan was administered, patient had the following side effects: completed suicide, intentional misuse. Calan dosage: Oral. During the same period patient was treated with CHLORPROMAZINE (Oral) (View Chlorpromazine Review and Chlorpromazine Label ).

4780435-8 | Completed Suicide, Intentional Misuse
on Sep 14, 2005 Female patient from UNITED STATES , 43 years of age, was diagnosed with ill-defined disorder and was treated with Calan (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, intentional misuse. Calan dosage: Oral. During the same period patient was treated with CLONIDINE (Oral) (View Clonidine Review and Clonidine Label ), ETHANOL (ETHANOL) (Oral) (View Ethanol (ethanol) Review and Ethanol (ethanol) Label ).

4780427-9 | Completed Suicide, Intentional Misuse, Overdose
Patient was taking Calan (View Usage). Patient had the following side effects: completed suicide, intentional misuse, overdose on Sep 14, 2005 from UNITED STATES Additional patient health information: Female patient , 37 years of age, was diagnosed with ill-defined disorder and. Calan dosage: Oral. During the same period patient was treated with TRANDOLARPIL (TRANDOLAPRIL) (Oral) (View Trandolarpil (trandolapril) Review and Trandolarpil (trandolapril) Label ).

4780416-4 | Alcoholism, Completed Suicide, Intentional Misuse, Overdose
Adverse event was reported on Sep 14, 2005 by a Female patient taking Calan (View Usage) (Dosage: Oral) was diagnosed with ill-defined disorder and. Location: UNITED STATES , 36 years of age, After Calan was administered, patient had the following side effects: alcoholism (What is alcoholism?), completed suicide, intentional misuse, overdose. During the same period patient was treated with ETHANOL (ETHANOL) (Oral) (View Ethanol (ethanol) Review and Ethanol (ethanol) Label ).

4780407-3 | Completed Suicide, Intentional Misuse
on Sep 14, 2005 Female patient from UNITED STATES , 71 years of age, was diagnosed with ill-defined disorder and was treated with Calan (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, intentional misuse. Calan dosage: Oral. During the same period patient was treated with METOPROLOL TARTRATE (Oral) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LISINOPRIL (Oral) (View Lisinopril Review and Lisinopril Label ).

4780283-9 | Alcohol Use, Completed Suicide, Intentional Misuse
on Sep 14, 2005 Female patient from UNITED STATES , 32 years of age, was diagnosed with ill-defined disorder and was treated with Calan (View Usage). Patient had the following side effects: alcohol use, completed suicide, intentional misuse. Calan dosage: Oral. During the same period patient was treated with TRANDOLAPRIL (Oral) (View Trandolapril Review and Trandolapril Label ), ETHANOL (ETHANOL) (Oral) (View Ethanol (ethanol) Review and Ethanol (ethanol) Label ).

4776582-7 | Diabetes Mellitus Non-insulin-dependent
Patient was taking Calan (View Usage). After Calan was administered, patient had the following side effects: diabetes mellitus non-insulin-dependent on Sep 12, 2005 from UNITED STATES Additional patient health information: Female patient , weighting 165.0 lb, was diagnosed with hypertension and. Calan dosage: 240 Mg (20 Mg, Daily), Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

4759494-4 | Hepatitis
Adverse event was reported on Aug 19, 2005 by a Female patient taking Calan (View Usage) (Dosage: ) was diagnosed with migraine (What is migraine?), ill-defined disorder and. Location: UNITED STATES , 61 years of age, weighting 115.0 lb, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?). During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ).

4757342-X | Adverse Event, Diabetes Mellitus Non-insulin-dependent
on Aug 16, 2005 Female patient from UNITED STATES , weighting 165.0 lb, was diagnosed with hypertension and was treated with Calan (View Usage). Patient had the following side effects: adverse event, diabetes mellitus non-insulin-dependent. Calan dosage: 240 Mg (240 Mg, Daily), Oral. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ).

4753212-1 | Accidental Overdose, Arthralgia, Back Pain, Blood Pressure Decreased, Blood Pressure Fluctuation, Emotional Distress, Feeling Abnormal, Feeling Drunk, Headache
on Aug 15, 2005 Female patient from UNITED STATES , 49 years of age, weighting 185.0 lb, was diagnosed with blood pressure (What is blood pressure?), migraine (What is migraine?) and was treated with Calan (View Usage). After Calan was administered, patient had the following side effects: accidental overdose, arthralgia, back pain (What is back pain?), blood pressure decreased, blood pressure fluctuation, emotional distress, feeling abnormal, feeling drunk, headache (What is headache?). Calan dosage: 480 Mg (240 Mg, Twice Daily). During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), PREVACID (View Prevacid Review and Prevacid Label ), VALIUM (View Valium Review and Valium Label ), DICLOXACILLIN (View Dicloxacillin Review and Dicloxacillin Label ).

4751734-0 | Bipolar Disorder, Eating Disorder, Hypomania, Impaired Work Ability, Insomnia, Major Depression, Malaise
Patient was taking Calan (View Usage). Patient experienced the following unwanted or unexpected effects: bipolar disorder (What is bipolar disorder?), eating disorder (What is eating disorder?), hypomania, impaired work ability, insomnia, major depression, malaise on Aug 22, 2005 from UNITED STATES Additional patient health information: Female patient , 43 years of age, weighting 130.0 lb, was diagnosed with migraine (What is migraine?) and. Calan dosage: 125mg./ 2 Per Day With Meal Once A Day Po. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

4743364-1 | Abdominal Discomfort, Arthralgia, Blood Pressure Decreased, Carotid Artery Disease, Feeling Abnormal, Feeling Drunk, Headache, Heart Rate Decreased, Lethargy
Adverse event was reported on Jul 27, 2005 by a Female patient taking Calan (View Usage) (Dosage: 480 Mg (240 Mg, Twice Daily), 10 Years Ago) was diagnosed with blood pressure (What is blood pressure?) and. Location: UNITED STATES , 49 years of age, weighting 185.0 lb, Patient had the following side effects: abdominal discomfort, arthralgia, blood pressure decreased, carotid artery disease (What is carotid artery disease?), feeling abnormal, feeling drunk, headache (What is headache?), heart rate decreased, lethargy. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), PREVACID (View Prevacid Review and Prevacid Label ), VALIUM (View Valium Review and Valium Label ), DICLOXACILLIN (View Dicloxacillin Review and Dicloxacillin Label ).

4737342-6 | Blood Glucose Decreased, Blood Pressure Increased, Chest Pain, Feeling Abnormal, Heart Rate Increased, Movement Disorder, Prescribed Overdose, Refusal Of Treatment By Patient, Tremor
on Jul 26, 2005 Female patient from UNITED STATES , 48 years of age, weighting 248.0 lb, was diagnosed with hypertension, blood cholesterol increased, asthma (What is asthma?), diabetes mellitus and was treated with Calan (View Usage). After Calan was administered, patient had the following side effects: blood glucose decreased, blood pressure increased, chest pain (What is chest pain?), feeling abnormal, heart rate increased, movement disorder (What is movement disorder?), prescribed overdose, refusal of treatment by patient, tremor. Calan dosage: 180 Mg (180 Mg, Every Evening), Oral. During the same period patient was treated with LIPITOR (2 Years Ago) (View Lipitor Review and Lipitor Label ), COVERA HS (240 Mg (240 Mg, Daily Interval: Every Evening) 4-5 Years Ago - Ongoing) (View Covera-hs Review and Covera-hs Label ), VERAPAMIL (180 Mg (180 Mg, Daily Interval: Every Evening)) (View Verapamil Review and Verapamil Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), INSULIN (View Insulin Review and Insulin Label ), MONTELUKAST (MONTELUKAST) (View Montelukast (montelukast) Review and Montelukast (montelukast) Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), ZOCOR (View Zocor Review and Zocor Label ).

4712623-0 | Echocardiogram Abnormal, Joint Swelling, Oedema Peripheral, Pulmonary Hypertension, Refusal Of Treatment By Patient, Sleep Apnoea Syndrome
on Jun 30, 2005 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with hypertension and was treated with Calan (View Usage). Patient experienced the following unwanted or unexpected effects: echocardiogram abnormal, joint swelling, oedema peripheral, pulmonary hypertension (What is pulmonary hypertension?), refusal of treatment by patient, sleep apnoea syndrome. Calan dosage: 250 Mg (250 Mg, Daily), Oral. During the same period patient was treated with ZESTRIL (View Zestril Review and Zestril Label ), PREMPRO ESTROGENS CONJUGATED, MEDROXPROGESTERONE ACETATE) (View Prempro Estrogens Conjugated, Medroxprogesterone Acetate) Review and Prempro Estrogens Conjugated, Medroxprogesterone Acetate) Label ).

4699068-7 | Feeling Abnormal
Patient was taking Calan (View Usage). Patient had the following side effects: feeling abnormal on Jun 22, 2005 from Additional patient health information: Female patient , 54 years of age, weighting 145.0 lb, was diagnosed with hypertension and. Calan dosage: 1 Daily.

4699059-6 | Feeling Abnormal
Adverse event was reported on Jun 22, 2005 by a Male patient taking Calan (View Usage) (Dosage: 1 Daily) was diagnosed with hypertension and. Location: , 56 years of age, weighting 219.0 lb, After Calan was administered, patient had the following side effects: feeling abnormal.

4615424-7 | Completed Suicide
on Mar 02, 2005 Female patient from , 38 years of age, was diagnosed with ill-defined disorder and was treated with Calan (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Calan dosage: Oral. During the same period patient was treated with THEOPHYLLINE (View Theophylline Review and Theophylline Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

4610286-6 | Blood Pressure Increased, Dizziness, Heart Rate Increased, Refusal Of Treatment By Patient, Restlessness
on Mar 02, 2005 Female patient from , 48 years of age, weighting 195.0 lb, was diagnosed with hypertension and was treated with Calan (View Usage). Patient had the following side effects: blood pressure increased, dizziness (What is dizziness?), heart rate increased, refusal of treatment by patient, restlessness. Calan dosage: 240 Mg (240 Mg, Daily), Oral. During the same period patient was treated with VERAPAMIL HCL (View Verapamil Hcl Review and Verapamil Hcl Label ), MONTELUKAST (MONTELUKAST) (View Montelukast (montelukast) Review and Montelukast (montelukast) Label ), SALBUTAMOL (SALBUTAMOL) (View Salbutamol (salbutamol) Review and Salbutamol (salbutamol) Label ), INSULIN (View Insulin Review and Insulin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), POTASSIUM ACETATE (View Potassium Acetate Review and Potassium Acetate Label ), FUROSEMIDE (FUROSEMIDE) (View Furosemide (furosemide) Review and Furosemide (furosemide) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).